Clinical Trials Browser

NCT06904235 2026-03-31

Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)

Phase 2 Recruiting

95 enrolled

Nausea, Vomiting

NCT07169851 2026-03-20

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Phase 2 Recruiting

204 enrolled

Nausea, Neoplasms, Vomiting, Drug-Related Side Effects and Adverse Reactions

NCT07403370 2026-02-11

Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis

Recruiting

2,000 enrolled

Nausea, Vomiting

NCT06769165 2025-12-11

EMESIS

Phase NA Recruiting

20 enrolled

Nausea, Vomiting

NCT03118986 2025-10-08

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Phase 2 Recruiting

200 enrolled

Nausea, Neoplasms, Vomiting

NCT07038551 2025-07-02

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

Phase 4 Recruiting

120 enrolled

Other

Opioid-Induced Constipation, Constipation, Nausea, Vomiting

NCT06200168 2025-04-02

Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer

Phase 3 Recruiting

370 enrolled

Breast

Breast Neoplasms, Nausea, Vomiting

NCT06726291 2024-12-10

NOEME

Phase 4 Recruiting

84 enrolled

Gynecologic

Nausea, Vomiting, Endometrial Neoplasms

NCT06588413 2024-11-22

FONDO-LOW

Phase 3 Recruiting

172 enrolled

Plasma cell

Multiple Myeloma, Nausea

NCT05838638 2024-05-16

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

Phase NA Recruiting

610 enrolled

Nausea, Neoplasms, Vomiting, Drug-Related Side Effects and Adverse Reactions

NCT06314906 2024-03-21

Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer

Phase 3 Recruiting

370 enrolled

Breast

Breast Neoplasms, Nausea, Vomiting

NCT06017284 2023-11-24

PTCA199-5

Phase 3 Recruiting

100 enrolled

Gastrointestinal

Nausea, Pancreatic Neoplasms, Vomiting

NCT05690802 2023-01-19

TSEPHCC

Phase NA Recruiting

1,060 enrolled

Nausea, Vomiting